Virological and immunological predictors of long term outcomes of peginterferon alfa-2a therapy for HBeAg-negative chronic hepatitis BArticle Published on 2021-09-012023-06-13 Journal: Journal of the Formosan Medical Association = Taiw [Category] B형 간염, [키워드] Chronic Hepatitis B CXCL9 HBsAg loss peginterferon alfa-2a [DOI] 10.1016/j.jfma.2020.12.001
Quantitation of large, middle and small hepatitis B surface proteins in HBeAg-positive patients treated with peginterferon alfa-2aArticle Published on 2020-02-012023-06-13 Journal: Liver international : official journal of the Inte [Category] B형 간염, [키워드] HBs proteins HBsAg peginterferon alfa-2a predictors of response Subviral particles [DOI] 10.1111/liv.14298
Hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis BRandomized Controlled Trial Published on 2019-10-012023-06-19 Journal: Journal of viral hepatitis [Category] B형 간염, [키워드] antiviral treatment response Biomarker hepatitis B peginterferon alfa-2a [DOI] 10.1111/jvh.13117 [Article Type] Randomized Controlled Trial
Genetic variation in FCER1A predicts peginterferon alfa-2a-induced hepatitis B surface antigen clearance in East Asian patients with chronic hepatitis BClinical Trial Published on 2019-09-012023-06-18 Journal: Journal of viral hepatitis [Category] B형 간염, [키워드] Chronic Hepatitis B Genetic variation peginterferon alfa-2a response [DOI] 10.1111/jvh.13107 [Article Type] Clinical Trial
CD56bright natural killer cells induce HBsAg reduction via cytolysis and cccDNA decay in long-term entecavir-treated patients switching to peginterferon alfa-2aArticle Published on 2018-11-012023-06-19 Journal: Journal of viral hepatitis [Category] B형 간염, [키워드] Chronic Hepatitis B covalently closed circular DNA hepatitis B surface antigen natural killer cell peginterferon alfa-2a [DOI] 10.1111/jvh.12946
Efficacy of Pegylated Interferon Monotherapy versus Sequential Therapy of Entecavir and Pegylated Interferon in Hepatitis B e Antigen-Positive Hepatitis B Patients: A Randomized, Multicenter, Phase IIIb Open-Label Study (POTENT Study)Clinical Trial Published on 2018-07-202023-06-16 Journal: Chinese medical journal [Category] B형 간염, [키워드] entecavir hepatitis B peginterferon alfa-2a [DOI] 10.4103/0366-6999.235880 PMC 바로가기 [Article Type] Clinical Trial
Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis BClinical Trial Published on 2018-07-012023-06-19 Journal: Journal of the Formosan Medical Association = Taiw [Category] B형 간염, [키워드] Adefovir Chronic Hepatitis B entecavir Hepatitis B e antigen peginterferon alfa-2a [DOI] 10.1016/j.jfma.2017.12.007 [Article Type] Clinical Trial
[Chronic hepatitis B and D (delta) : Current and future treatments]Review Published on 2018-06-012023-06-19 Journal: Internist (Berl) [Category] B형 간염, [키워드] functional cure Hepatitis B virus Hepatitis Delta virus nucleos(t)ide analogues peginterferon alfa-2a [DOI] 10.1007/s00108-018-0432-3 [Article Type] Review
Peginterferon alfa-2a for the treatment of chronic hepatitis C in the era of direct-acting antiviralsReview Published on 2017-10-152023-06-18 Journal: Hepatobiliary & pancreatic diseases international : HBPD INT [Category] B형 간염, [키워드] chronic hepatitis C Direct-acting antivirals hepatitis C virus peginterferon alfa-2a ribavirin [DOI] 10.1016/S1499-3872(17)60044-4 [Article Type] Review
Viral minority variants in the core promoter and precore region identified by deep sequencing are associated with response to peginterferon and adefovir in HBeAg negative chronic hepatitis B patientsArticle Published on 2017-09-012023-06-19 Journal: Antiviral Research [Category] B형 간염, [키워드] Adefovir Hepatitis B e antigen Mutation peginterferon alfa-2a Response marker Ultra-deep pyrosequencing. [DOI] 10.1016/j.antiviral.2017.07.013